‘Cancer is a life sentence. But Covid is a death sentence’: Patients with compromised immune systems unable to access vaccines

Print Friendly, PDF & Email
Credit: FatCamera
Credit: FatCamera

Facing conflicting guidance and logistical chaos, many cancer patients are struggling to navigate the bumpy rollout of the Covid-19 vaccination campaign. Ideally, cancer patients who take immunosuppressant medications should receive vaccinations under the care of a doctor, or in a cancer center, where they can be closely monitored and encounter fewer people than they would at a mass distribution site. But the limited availability of the vaccine, plus the havoc and confusion surrounding the rollout, leaves patients grasping for answers.

“It’s really frustrating when you’re a stage four cancer patient and you can’t get on the list,” said Connie Johnson, 62. “Cancer is a life sentence. But Covid is a death sentence.”

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

Ms. Johnson is part of a Facebook group for cancer patients, many of whom express rage and frustration over the vaccine roll out. “It’s a full-time job just managing chemo and side effects,” she said. “To have to go through all of this confusion — I think a lot of them are going to throw up their hands.”

According to the American Cancer Society, initial studies testing the Covid-19 vaccines did not include people receiving treatments, like chemotherapy, that suppress the immune system… As a result, it’s not clear how cancer patients in active treatment will respond to the vaccine.

“This has been a complete — I won’t say disaster, but it’s been pretty close,” said [hematologist] Dr. Hanny Al-Samkari.

Read the original post 

Related article:  Recovery is elusive for this COVID longhauler
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists